DISCLOSURE OF STRATEGIC REALIGNMENT OF DRUG DEVELOPMENT ACTIVITIES

Company

LadRx Corp

Filed

November 8, 2017

Period of Report

October 31, 2017

Accession Number

0000799698-17-000037

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →